First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting

被引:0
|
作者
Dennen, Syvart
Harton, Joanna
Cockrum, Paul
Kim, George P.
MacEwan, Joanna P.
机构
[1] Genesis Res Grp, Hoboken, NJ USA
[2] Ipsen Biopharmaceut Inc, Cambridge, MA USA
[3] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16320
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Real-world treatment patterns and total cost of care in Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
    Hirsch, Jared
    Cockrum, Paul
    Tomicki, Samantha
    Dieguez, Gabriela
    Bhatt, Prachi
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    King, Gentry
    Ittershagen, Stacie
    He, Luyang
    Shen, Ying
    Li, Frank
    Villacorta, Reginald
    ADVANCES IN THERAPY, 2022, 39 (12) : 5433 - 5452
  • [3] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    Gentry King
    Stacie Ittershagen
    Luyang He
    Ying Shen
    Frank Li
    Reginald Villacorta
    Advances in Therapy, 2022, 39 : 5433 - 5452
  • [4] Dosing patterns and treatment patterns in real-world patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line
    MacEwan, Joanna P.
    Silver, Michelle
    Cockrum, Paul
    Sanders, Chad
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Patterns of treatment switching and healthcare resource utilization differences among real-world Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
    Dieguez, Gabriela
    Hirsch, Jared
    Cockrum, Paul
    Bhatt, Prachi
    Tomicki, Samantha
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Adverse events in real-world patients covered by Medicare with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
    Dieguez, Gabriela
    Tomicki, Samantha
    Cockrum, Paul
    Hirsch, Jared
    Bhatt, Prachi
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.
    Taieb, Julien
    Hammel, Pascal
    Reni, Michele
    Palmer, Daniel H.
    Bridgewater, John A.
    Cubillo, Antonio
    Prager, Gerald W.
    Vermeire, Alice
    D'Esquermes, Nathalie
    Biville-Hedouin, Fabienne
    Teng Zhaoyang
    Seufferlein, Thomas
    Macarulla, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [8] Real-world patterns of pain medication use among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Laursen, Ashley Ann
    Surinach, Andy
    Wang, Shu
    Cockrum, Paul
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [9] Real-World First-Line Treatment Patterns Among US Carcinoid Syndrome Patients
    Sun, Gordon H.
    Neary, Maureen P.
    Chang, Eunice
    Broder, Michael S.
    PANCREAS, 2015, 44 (02) : 359 - 360
  • [10] Real-world Impact of Age at Diagnosis on Treatment Patterns and Survival Outcomes of Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    Elias, Rawad
    Cockrum, Paul
    Surinach, Andy
    Wang, Shu
    Chu, Bong Chul
    Shahrokni, Armin
    ONCOLOGIST, 2022, 27 (06): : 469 - 475